UPDATE 1-Eli Lilly stops development of lupus drug; XTL shares soar
October 02, 2014 at 11:25 AM EDT
Oct 2 (Reuters) - Eli Lilly and Co said it would stop the development of its drug to treat the autoimmune disorder lupus, after it was found to be not effective enough in late-stage trials.
